Leishmaniasis is a poverty related disease caused by protozoan parasites belonging to the genus Leishmania.
No effective vaccine is presently available to treat this disease. The present study identifies specific epitopes in highly
antigenic peptides of Leishmania infantum. Interestingly we found amastin like surface proteins as relevant markers for
vaccine development for design of epitopes. A major glycoprotein GP63 leishmanolysin which directly binds to human
natural killer cells (NK cells) was also selected as highly antigenic and considered for the analysis. Overall two different
amastin like surface proteins were found as relevant for designing 9-mer epitopes for vaccine development against L.
infantum and the best identified antigenic segments interacted with at least 8 alleles of each MHC classes. These epitopes
are potential candidates to induce both T cell and B cell mediated immune responses.
Keywords: Amastin, Antigenic, Epitopic analysis, Human, In silico, Leishmania, Vaccine development, L. infantum, NK cells, Leishmania donovani, HIV/AIDS, VL, Helicobacter pylori, GP63 leishmanolysin, Amastin, fold-level analysis, CD-HIT
Rights & PermissionsPrintExport